ESMO Virtual 2020: Biomarker-guided therapy in metastatic kidney cancer
Yesterday, findings from the phase 2 biomarker trial, BIONIKK, were [...]
Yesterday, findings from the phase 2 biomarker trial, BIONIKK, were [...]
Non-clear cell renal cell carcinoma (RCC) accounts for about 25% [...]
At the European Society of Medical Oncology (ESMO) Virtual Congress [...]
These two videos with Dr Eric Jonasch from MD Anderson [...]
In this video interview Professor Jens Bedke from the Department [...]
In this retrospective study published in Cancer Reports the association [...]
A recent study coming out of China has identified a [...]
An educational symposium was held from 8-10 August as part [...]
A recent online survey involving 41 kidney cancer experts worldwide [...]
Because so little was known about coronavirus at the start [...]